نتائج البحث - Simon Rule
- يعرض 1 - 20 نتائج من 53
- اذهب إلى الاصفحة التالية
-
1
Mantle cell lymphoma: evolving management strategies حسب Elı́as Campo, Simon Rule
منشور في 2014Revisão -
2
-
3
-
4
Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in Haematology حسب Gail Jones, Andrew Will, Graham Jackson, Nicholas J.A. Webb, Simon Rule
منشور في 2015Artigo -
5
-
6
-
7
-
8
-
9
-
10
Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up حسب M. Dreyling, Elı́as Campo, Olivier Hermine, Mats Jerkeman, Steven Le Gouill, Simon Rule, Ofer Shpilberg, Jan Walewski, Marco Ladetto
منشور في 2017Artigo -
11
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up حسب M. Dreyling, Michele Ghielmini, Simon Rule, Gilles Salles, Marco Ladetto, Sanne H. Tonino, Klaus Herfarth, John F. Seymour, Mats Jerkeman
منشور في 2020Artigo -
12
Single‐agent lenalidomide in relapsed/refractory mantle cell lymphoma: results from a <scp>UK</scp> phase II study suggest activity and possible gender differences حسب Heather E. Eve, S. Carey, Sarah J. Richardson, Carla Heise, Vidya Mamidipudi, Tao Shi, John Radford, Rebecca Auer, Sheila Bullard, Simon Rule
منشور في 2012Artigo -
13
Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up حسب M. Dreyling, Carsten Geisler, Olivier Hermine, Hanneke C. Kluin‐Nelemans, Steven Le Gouill, Simon Rule, Ofer Shpilberg, Jan Walewski, Marco Ladetto
منشور في 2014Artigo -
14
S101 EFFICACY AND SAFETY OF PROLONGED MAINTENANCE WITH SUBCUTANEOUS RITUXIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA: RESULTS OF THE PHASE III MABCUT... حسب Simon Rule, Wolney Barreto, Javier Briones, A Carella, Christopher Pocock, C.‐M. Wendtner, Francesco Zaja, Susan Robson, Roger R. Tschopp, Martin Dreyling
منشور في 2019Artigo -
15
Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: major prognostic impact of HLA class I identity... حسب Andrew Spencer, Richard Szydlo, PA Brookes, É. Kaminski, Simon Rule, Frits van Rhee, K.N. Ward, G Hale, Herman Waldmann, JM Hows
منشور في 1995Artigo -
16
Ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma: extended 3.5-year follow up from a pooled analysis حسب Simon Rule, Martin Dreyling, André Goy, Georg Heß, Rebecca Auer, Brad S. Kahl, José‐Ángel Hernández‐Rivas, Keqin Qi, Sanjay Deshpande, Lori Parisi, Michael Wang
منشور في 2018Carta -
17
The EBMT/EMCL consensus project on the role of autologous and allogeneic stem cell transplantation in mantle cell lymphoma حسب Stephen Robinson, Peter Dreger, Dolores Caballero, Paolo Corradini, Carsten Geisler, Michele Ghielmini, Steven Le Gouill, Eva Kimby, Simon Rule, Umberto Vitolo, M. Dreyling, Olivier Hermine
منشور في 2014Artigo -
18
-
19
Subcutaneous Rituximab for the Treatment of B-Cell Hematologic Malignancies: A Review of the Scientific Rationale and Clinical Development حسب Andrew Davies, Claude Berge, Axel Boehnke, Anjum Dadabhoy, Pieternella J. Lugtenburg, Simon Rule, Mathias Rummel, Christine McIntyre, Rodney B.W. Smith, Xavier C. Badoux
منشور في 2017Revisão -
20
Weekly <i>versus</i> twice weekly bortezomib given in conjunction with rituximab, in patients with recurrent follicular lymphoma, mantle cell lymphoma and Waldenström macroglobulin... حسب A. Agathocleous, A. Z. S. Rohatiner, Simon Rule, Hannah Hunter, Jonathan P. Kerr, S. Neeson, Janet Matthews, Sandra J. Strauss, Silvia Montoto, Peter Johnson, John Radford, Andrew Lister
منشور في 2010Artigo
أدوات البحث:
موضوعات ذات صلة
Internal medicine
Medicine
Lymphoma
Oncology
Leukemia
Mantle cell lymphoma
Chronic lymphocytic leukemia
Ibrutinib
Gastroenterology
Rituximab
Chemotherapy
Refractory (planetary science)
Clinical trial
Surgery
Adverse effect
Astrobiology
Phases of clinical research
Immunology
Biology
Follicular lymphoma
Physics
Clinical endpoint
Confidence interval
Multiple myeloma
Transplantation
Cancer research
Family medicine
Pathology
Bendamustine
Hazard ratio